Impact of Non-glucose Signals on Glycemic Control in Patients With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Type 1 Diabetes Mellitus
Interventions
OTHER

Observation During Exercise and Stress

"Patients with type 1 diabetes (T1D) on an insulin pump will be studied for 5 weeks in the outpatient setting performing their normal activities, to include their normal diet and exercise, while assessing the amount of type of exercise performed, and emotional stress levels, using stress sensor, questionnaires and salivary cortisol levels.~Subjects at the William Sansum Diabetes Center will perform graded exercise on a treadmill for up to 45 minutes with all activity and stress monitors running, achieving 30 and 60% calculated heart rate reserve, once during the study. Subjects at Mayo Clinic will perform a graded exercise test on a treadmill to determine V02max and ensure stable cardiac status, once during the study."

Trial Locations (2)

55905

Mayo Clinic, Rochester

93111

Sansum Diabetes Research Institute, Santa Barbara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Harvard University

OTHER

lead

Sansum Diabetes Research Institute

OTHER